Concepedia

Boris S. Naroditsky

BS

61

Publications

5.2K

Citations

28

H-Index

1978

Active since

Affiliations

Gamalei Institute of Epidemiology and Microbiology(Current)

Ministry of Health of the Russian Federation

Sechenov University

Lomonosov Moscow State University

All-Russian Scientific Research Institute of Food Biotechnology

Boris S. Naroditsky is an author at Gamalei Institute of Epidemiology and Microbiology specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

1978–2023

61

Publications

61

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet · 2021 · 1.8K citations · Full text

, , +10

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova et al. · The Lancet · 2020 · 1.1K citations · Full text

, , +7

Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds

Svetlana A. Ermolaeva, Alexander F. Varfolomeev, M.Y. Chernukha et al. · Journal of Medical Microbiology · 2010 · 327 citations

, , +17

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

Inna V. Dolzhikova, Olga V. Zubkova, Amir I. Tukhvatulin et al. · Human Vaccines & Immunotherapeutics · 2017 · 132 citations · Full text

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist

Lyudmila G. Burdelya, Craig M. Brackett, Bojidar Kojouharov et al. · Proceedings of the National Academy of Sciences · 2013 · 120 citations · Full text

Rows per page

1–5 of 61